Extending Canine Lifespan: A Veterinary Breakthrough

This chapter explores a pioneering drug development by a biotech company aimed at extending the lifespan of dogs, particularly large breeds. With initial signs of FDA approval, the discussion covers the scientific basis behind canine longevity, including the role of the IGF-1 hormone and the effects of selective breeding. Ethical considerations regarding veterinary medicine investment and upcoming trials for pet owners are also addressed.